ArticleFrontiers in medicine2025
To treat or not to treat? Oncologists' perceptions and experiences regarding overtreatment in end stage cancer patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Aggressive care at end-of-life can harm quality of life without significantly improving survival. Despite best practice guidelines, research shows that oncologists continue to provide too much treatment to patients, especially at the end-of-life. Understanding the perceptions of oncologists regarding unnecessary care toward end-of-life can inform interventions and mitigate overuse. This study aimed to understand the perceptions and experiences of oncologists regarding why overuse of services is occurring for cancer patients at the end-of-life and elucidate factors which impede the implementation of best practices at the end-of-life in cancer. Methods: In-depth, semi-structured interviews were conducted with oncologists in Israel. The interview guide was based on the Theoretical Domains Framework to identify beliefs about practices in caring for patients at the end-of-life and transitioning to palliative care. Interviews were audio-recorded, transcribed, coded, and thematically analyzed. Results: Participants identified six major barriers and 12 major facilitators to reducing overuse at end-of-life. Barriers included patients seeking second opinions, patient and family fragility, pressure and demands from patients and families, a culture of valuing extending life, time constructs, and physicians' emotional regulation. Physicians reduce overuse by relying on experience, communication and relationship building skills, taking ownership over their roles, confidence in their abilities, belief and recognition of the importance of appropriate care, involving families and other healthcare professionals and easing into the process. Oncologist opinions vary based on role and geographical area of practice. Conclusion: Physicians can influence the rate of overuse as they guide patients at end-of-life. Findings can be utilized to help the health system in Israel reduce the overuse of unnecessary services at the end-of-life for cancer. Interventions such as palliative care referrals, multidisciplinary teams, and educational initiatives can help minimize overuse and improve quality of life for patients in their final days. Future research should incorporate views and perspectives of other stakeholders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.